Organizational Restructuring and Personnel Changes

December 10, 2009 (Tokyo) - Chugai Pharmaceutical Co., Ltd. [Head office: Chuo-ku, Tokyo; President: Osamu Nagayama] announced today that the company will make organizational and personnel changes, effective January 1, 2010.

Details of Organizational Restructuring
1. Reorganization of Corporate staff organization
   - Set up "Supervisory Divisions" within the Corporate staff organization, making them top organizations that consolidate
     closely-related duties. And Heads of Supervisory Divisions will be established with authority and responsibility for a
     broad range of roles.
   - Transfer Intellectual Property Dept. from Corporate staff organization to Portfolio Management Unit.

2. Reorganization of Lifecycle Management & Marketing Unit
Integrate LCM Department 1-3 and DAS Department 1-3 into 3 departments according to their responsible therapeutic
areas. The names of new departments will be LCM Department 1, LCM Department 2 and LCM Department 3.

3. Reorganization of Clinical Development Division
Consolidate 9 departments into 3 departments: Clinical Research Coordination, Clinical Research Planning and Clinical
Research.

Details of Personnel Changes
Board Member

Name	New Responsibilities	Old Responsibilities
Osamu Nagayama	Representative Director, President and CEO, COO, Corporate Planning Supervisory Div. (Corporate Planning, External Affairs)	Representative Director, President and CEO, COO
Motoo Ueno	Representative Director, Deputy President Pharmaceutical Technology, Corporate Social Responsibility, Audit	Representative Director, Deputy President Corporate Social Responsibility, Pharmaceutical Technology
Ryuzo Kodama	Director, Executive Vice President CFO, IT Supervisory Div. (Information System, ERP System), General Manager of Finance Supervisory Div., BPR	Director, Executive Vice President CFO, System and Corporate Communications (Information System, ERP System)
Tatsumi Yamazaki	Director, Executive Vice President Portfolio Management, Regulatory & Quality Management, Clinical Development, Drug Safety	Director, Executive Vice President Portfolio Management, Regulatory & Quality Management, Clinical Development, Drug Safety, Intellectual Property
Harutaka Fujita	Director, Executive Vice President Legal, Secretarial, General Affairs Supervisory Div. (General Affairs, Risk Management & Compliance), Human Resources Supervisory Div. (Human Resources Management, Human Capital Development, CBS)	Director, Executive Vice President Corporate Services and Human Resources (General Affairs, Risk Management & Compliance, Human Resources Management, Human Capital Development, Audit, CBS)

Executive Officer

Name	New Responsibilities	Old Responsibilities
Yoshio Itaya	Vice President General Manager of Corporate Planning Supervisory Div. and General Manager of Corporate Planning Dept.	Vice President General Manager of Corporate Planning Dept.
Hideaki Nagai	Vice President General Manager of IT Supervisory Div. and General Manager of Information Systems Dept.	Associate Vice President General Manager of Information System Dept.
Mamoru Togashi	Vice President General Manager of Human Resources Supervisory Div. and General Manager of Human Resources Management Dept.	General Manager of Human Resources Management Dept.
Kunitoshi Watanabe	Vice President General Manager of General Affairs Supervisory Div. and General Manager of General Affairs Dept.	General Manager of General Affairs Dept.
Toshihiko Tsuchiya	Vice President General Manager of Secretarial Dept.	Senior Specialist of Secretarial Dept.
Masaharu Unno	Vice President Senior Specialist of Secretarial Dept.	Vice President General Manager of Secretarial Dept.

Please see the PDF file about other personnel changes.

[ PDF 78KB]

To view PDF files,
you will need Adobe® Reader® which is available as a free download.